NEW YORK (GenomeWeb) – Researchers from Stanford University have demonstrated in mice a technique for inducing tumors to release a detectable biomarker that they hope can be developed into a method for early cancer detection in humans.
The study, published this week in Proceedings of the National Academy of Sciences, was a proof of principle that the team's approach could distinguish mice implanted with human melanoma cells from those without.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
